Medicine and Dentistry
Hyperthermic Intraperitoneal Chemotherapy
92%
Neoplasm
84%
Cytoreductive Surgery
75%
Surgical Anastomosis
55%
Overall Survival
53%
Sleeve Gastrectomy
49%
Lymph Node Metastasis
46%
Retroperitoneal Sarcoma
46%
Indocyanine Green
46%
Recurrent Disease
44%
Gastric Bypass Surgery
43%
Gastric Bypass
43%
Peritoneum Metastasis
42%
Pancreas Adenocarcinoma
37%
Acetylcholinesterase Inhibitor
37%
Disease
36%
Cancer
33%
Surgeon
31%
Postoperative Complication
30%
Nodular Melanoma
30%
Metastatic Carcinoma
28%
Intraperitoneal Chemotherapy
27%
Peritoneum Mesothelioma
26%
Neuroinflammation
24%
Bariatric Surgery
23%
Soft Tissue Sarcoma
23%
Immune Response
22%
Lymph Node
21%
Desmoplasia
21%
Liposome
21%
Sarcoma
20%
Surgery
20%
Malignant Neoplasm
20%
Incision
19%
Gastroesophageal Reflux
19%
Carcinomatous Peritonitis
18%
Elderly Patient
18%
Abdominal Wall Hernia
18%
Urinary System
18%
Roux-en-Y Gastric Bypass
18%
Quality of Life
18%
Sentinel Lymph Node Biopsy
18%
Melanoma
18%
Myasthenia gravis
15%
Patient Referral
13%
Upregulation
13%
Surgical Mesh
13%
Rectum Cancer
12%
Tumor Imaging
12%
Rectum Tumor
12%
Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Cytoreductive Surgery
64%
Retroperitoneal Sarcoma
55%
One-anastomosis Gastric Bypass
46%
Sleeve Gastrectomy
41%
Overall Survival
41%
Lymph Node Metastasis
39%
Acetylcholinesterase Inhibitors (AChEI)
38%
Neuroinflammation
37%
Liposomal
37%
Cholinergic Modulation
37%
Indocyanine Green
37%
Peritoneal Metastasis
35%
Pancreatic Ductal Adenocarcinoma
33%
Peritoneal Surface Malignancy
28%
Bifunctional Compounds
27%
Immune Response
26%
Tumor
25%
Melanoma
23%
Anti-inflammatory Activity
23%
Desmoplasia
23%
Cholinergic System
22%
Bariatric Surgery
21%
Cytoreduction
21%
Metabolic Surgery
20%
Retrospective Analysis
20%
Lymph Node
19%
T Helper 1
19%
Metastatic Lymph Node
18%
Pancreatic Adenocarcinoma
18%
Sarcoma
18%
Elderly Patients
18%
Breast
18%
Peritoneal Mesothelioma
18%
Roux-en-Y Gastric Bypass
18%
One Anastomosis
18%
Israeli Society
18%
Severe Postoperative Complications
18%
Peritoneal Cancer Index
18%
Experimental Autoimmune Encephalomyelitis
18%
Nicotinic Acetylcholine Receptor (nAChR)
18%
Central Nervous System Inflammation
17%
Surgeons
16%
Confidence Interval
16%
Central Nervous System
16%
CD8+
15%
Acetylcholine
15%
Myasthenia Gravis
15%
Cholinergic Transmission
15%
Octyl
15%